News & Insights
OrganOx Announces $142 Million Equity Financing Led by HealthQuest Capital
- OrganOx has completed a $142m primary and secondary equity financing to accelerate the rollout of its metra devices.
- The oversubscribed round was led by external investor HealthQuest, alongside new investors Sofina, Soleus Capital, and Avidity Partners and with support from existing investors BGF and Lauxera Capital Partners.
The metra has already supported more than 5000 successful liver transplants across Europe, the US and Australia, and clinical adoption continues to grow.
The investment will support continued expansion, particularly in the US market, alongside further investment in new infrastructure both in the UK and US to support ongoing progress of the R&D pipeline.
Read the full press release here.